Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for OLN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 10.10M
March 31, 2026 116.20M
December 31, 2025 -199.70M
September 30, 2025 -36.70M
June 30, 2025 -73.20M
March 31, 2025 146.60M
December 31, 2024 -113.70M
September 30, 2024 -90.00M
June 30, 2024 16.40M
March 31, 2024 -25.30M
December 31, 2023 -258.20M
September 30, 2023 -153.60M
June 30, 2023 -260.70M
March 31, 2023 -28.50M
December 31, 2022 -277.10M
September 30, 2022 -639.40M
June 30, 2022 -441.20M
March 31, 2022 -289.00M
December 31, 2021 -553.60M
September 30, 2021 -460.60M
June 30, 2021 -408.50M
March 31, 2021 -129.30M
December 31, 2020 -131.00M
September 30, 2020 -148.60M
June 30, 2020 547.00M
Date Value
March 31, 2020 118.20M
December 31, 2019 -43.20M
September 30, 2019 -49.60M
June 30, 2019 -21.50M
March 31, 2019 -95.00M
December 31, 2018 -188.70M
September 30, 2018 -213.70M
June 30, 2018 -61.90M
March 31, 2018 -100.50M
December 31, 2017 -152.10M
September 30, 2017 112.10M
June 30, 2017 -43.60M
March 31, 2017 -33.20M
December 31, 2016 -62.70M
September 30, 2016 -49.90M
June 30, 2016 -174.80M
March 31, 2016 -50.10M
December 31, 2015 469.30M
September 30, 2015 -16.40M
June 30, 2015 -16.50M
March 31, 2015 -14.20M
December 31, 2014 -48.80M
September 30, 2014 -29.40M
June 30, 2014 -28.90M
March 31, 2014 -41.40M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Huntsman Corp. 13.00M
Ashland, Inc. -18.00M
The Chemours Co. -289.00M
Albemarle Corp. -80.05M
Core Molding Technologies, Inc. 0.00